Carregant...
31.4 GENETIC, IMMUNOLOGICAL AND BIOCHEMICAL MARKERS OF TREATMENT RESPONSE IN SCHIZOPHRENIA
BACKGROUND: One of the major shortcomings in the current treatment of schizophrenia is that we have no valid criteria in clinical practice to decide which antipsychotic treatment should be chosen first. This is why we need to define a blood-based biological signature of treatment response that can b...
Guardat en:
| Publicat a: | Schizophr Bull |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5888528/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.130 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|